Switch View
© PR Newswire
07.10.2025
ISIN: US15102K1007
Celcuity Inc
CELC
LISTED
NASDAQ
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
News Preview
USA News Group
News Commentary
Issued on behalf of GT Biopharma, Inc.
VANCOUVER, BC, Oct. 7, 2025 /CNW/ -- USA...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: DE0005313704
Carl Zeiss Meditec AG
AFX
LISTED
XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet Completes Acquisition of Monogram Technologies
News Preview
Transaction creates the
broadest, most flexible portfolio of orthopedic robotics and navigation technologies, including pathway towards the first fully autonomous robotic technology for orthopedic procedures
WARSAW, Ind., Oct. 7, 2025 /PRNewswire/ -- Zimmer B...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
07.10.2025
ISIN: US15102K1007
Celcuity Inc
CELC
LISTED
NASDAQ
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
News Preview
USA News Group
News Commentary
Issued on behalf of GT Biopharma, Inc.
VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
07.10.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
CVS Health opens new Workforce Innovation and Talent Center in Fort Worth
News Preview
In collaboration with Fort Worth Housing Solutions, the center offers no-cost training for Fort Worth's future health care workforce
FORT WORTH, Texas, Oct. 7, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) is expanding access to health care careers with the launc...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US15102K1007
Celcuity Inc
CELC
LISTED
NASDAQ
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
News Preview
USA News Group
News Commentary
Issued on behalf of GT Biopharma, Inc.
VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: DE0005313704
Carl Zeiss Meditec AG
AFX
LISTED
XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic Reports Positive Topline Data for Mpox/Smallpox Vaccine in Pediatric Population
News Preview
COPENHAGEN, Denmark, October 7, 2025 – Bavarian Nordic A/S (OMX: BAVA) today reported topline results from a clinical study of its MVA-BN® mpox/smallpox vaccine in children 2 to 11 years of age....
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US47973J1025
Joint Corp
JYNT
LISTED
NASDAQ
The Joint Chiropractic Continues Climb on the Franchise Times Top 400 List
News Preview
SCOTTSDALE, Ariz., Oct. 7, 2025 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, has been recognized on the annual Franchise Times Top 400. The list ranks the largest franchised systems, based in the United States, accordin...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: CA01559R4008
Algernon Pharmaceuticals Inc.
AGN
LISTED
CSE
Catalyst MedTech Launches "Connect" Program to Expand Access to Advanced Imaging; Announces Initial Partnership with Algernon Pharmaceuticals
News Preview
PITTSBURGH, Oct. 7, 2025 /PRNewswire/ -- Catalyst MedTech today announced the launch of its new Connect program, an initiative that brings together collaborators seeking to advance patient care with the access required to make it possible. Connect leverages Catalyst's unique dual business structure—Equipment Solu...
Themefolio
Profiler
Peergroup
© Newsfile
07.10.2025
ISIN: CA09073K1084
Biomark Diagnostics Inc.
BUX
LISTED
CSE
BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial
News Preview
Extensive Validation of BioMark's Comprehensive Metabolic Panel in German 10,000-Participant HANSE Study, within the context of an international consortium supported under the EUREKA Network.Vancouver, British Columbia--(Newsfile Corp. - October 7, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leadin...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US2290503075
Cryoport Inc
CYRX
LISTED
NASDAQ
MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars
News Preview
Connected, Intelligent Condition Monitoring Assets that Safeguard Vital Life Science Materials Mark MVE's First Step in its Real-Time Integrated Systems Evolution
NASHVILLE, Tenn., Oct. 7, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX), a global leader in su...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
07.10.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
News Preview
Final Clinical Visit Marks Major Milestone in First-in-Human Evaluation of Breast Cancer Vaccine
Comprehensive Immune Response and Safety Data to Be Presented at the San Antonio Breast Cancer Symposium in December...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
One A Day® Unveils Bold New Brand Identity and Platform: “The ONE for you”
News Preview
One A Day®, the multivitamin and supplement brand by Bayer rooted in 80+ years of nutritional science, today announced a bold new brand identity and positioning designed to better connect with today’s consumers and their evolving health needs. The rebrand, rolling out nationwide this fall, introduces a refreshed visual identity, packaging, and pur...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
TREMFYA® (guselkumab) is first and only IL-23 inhibitor to demonstrate sustained clinical and endoscopic outcomes with a fully subcutaneous regimen through 48 weeks in ulcerative colitis
News Preview
Patients treated with subcutaneous TREMFYA® achieved clinically meaningful results in both clinical remission (36.7%) and endoscopic remission (25.9%) at Week 48 in the Phase 3 ASTRO study
Clinical and endoscopic outcomes were demonstrated across both biologic-n...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Icotrokinra data in ulcerative colitis show potential for a standout combination of therapeutic benefit and a favorable safety profile in once-daily pill
News Preview
Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated with the highest dose achieving endoscopic improvement at Week 12 in the Phase 2b ANTHEM-UC study
These data support the promise of a first-in-class targ...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US09062W2044
BioLife Solutions Inc
BLFS
LISTED
NASDAQ
BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary
News Preview
BOTHELL, Wash., Oct. 7, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools for the cell and gene therapy ("CGT") market, announces the sale of SAVSU Cleo Technologies, LLC. (f/k/a SAVSU Technologies, Inc.) ("SAVSU"),...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US70387R4039
PAVmed, Inc.
PAVM
LISTED
NASDAQ
PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement
News Preview
The Veris Cancer Care Platform to be deployed to enhance personalized cancer care in patients undergoing systemic cancer therapy across OSUCCC – James
NEW YORK, Oct. 7, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified com...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: CA1380357048
Canopy Growth Corp
CGC
LISTED
NASDAQ
JP Brand Advisors and Canopy USA Form Strategic Partnership to Expand Hemp Beverage Distribution
News Preview
DALLAS, Oct. 7, 2025 /PRNewswire/ -- JP Brand Advisors ("JPBA"), the leading outsourced sales and strategy partner for beverage alcohol and emerging functional beverage brands, and Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the U.S. cannabis market, today announced...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US45781M1018
Innoviva Inc
INVA
LISTED
NASDAQ
Innoviva Specialty Therapeutics to Deliver Six Presentations from its Infectious Diseases and Critical Care Portfolio at IDWeek 2025
News Preview
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that it will deliver data from six presentations at IDWeek 2025, including clinical data, pharmacokinetic-pharmacodynamic (PK-PD) analyses, and microbiologic surveillance from its growing portfolio of antibiotics and critical care medicines. IDWeek will...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics Congratulates Scientific Advisor Dr. Shimon Sakaguchi for Receiving The Nobel Prize in Physiology or Medicine for Discovery of Regulatory T Cells and Immune Function
News Preview
Coya Therapeutics, Inc. (NASDAQ: COYA) congratulates our long-standing scientific advisor, Dr. Shimon Sakaguchi, on being awarded the Nobel Prize for his pioneering discovery of regulatory T cells (Tregs) which protect the body from autoimmune diseases. This discovery has reshaped modern immunology and opened new therapeutic frontiers.
Dr. Sakag...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US92764N1028
Vir Biotechnology Inc
VIR
LISTED
NASDAQ
Vir Biotechnology to Present Week 48 SOLSTICE Clinical Results in Hepatitis Delta at AASLD’s The Liver Meeting® 2025
News Preview
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will present Week 48 endpoint results from the SOLSTICE Phase 2 clinical study evaluating tobevibart alone, or in combination with elebsiran, in patients with chronic hepatitis delta in an oral presentation at the upcoming American Association for the Study of Liver Diseases (AASLD)...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US5747951003
Masimo Corporation
MASI
LISTED
NASDAQ
In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones
News Preview
Masimo (NASDAQ: MASI) today announced the findings of an exploratory analysis for a unique feasibility study published in CHEST Critical Care in which Dr. Andrew Goodwin and colleagues at the Medical University of South Carolina (MUSC) found that Masimo SET® pulse oximetry performed accurately among critically ill adult patients of all skin tones,...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025. Management will host a conference call that day to discuss third quarter 2025 financial and operating results at 8:30 a...
Themefolio
Profiler
Peergroup
© Newsfile
07.10.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data
News Preview
The Company expects to complete full enrollment by early 2026 and is moving its timelines up three to six months, cutting its anticipated capital needs by $10-$15 millionWhite Bear Lake, Minnesota--(Newsfile Corp. - October 7, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully im...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson Unveils New Data Demonstrating Superior Clarity of Vision and Comfort of ACUVUE OASYS MAX 1-Day for ASTIGMATISM, and MULTIFOCAL for ASTIGMATISM Contact Lenses
News Preview
Studies presented at #Academy25 reveal that ACUVUE OASYS MAX 1-Day for ASTIGMATISM outperformed Dailies Total1® for Astigmatism in patient reported outcomes related to vision and comfort.
Research highlights that the latest ACUVUE cont...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Join Cytokinetics, Incorporated Fraud Investigation with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ: CYTK) for violations of the securities laws....
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NUTX
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex " or "the Company") (NASDAQ: NUTX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities a...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics " or "the Company") (NASDAQ: CYTK ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Lantheus Holdings, Inc. ("Lantheus " or "the Company") (NASDAQ: LNTH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Sec...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: CA00830Q3061
Affinor Growers Inc.
AFI
LISTED
CSE
Canadian Investment Regulatory Organization Trading Halt - AFI
News Preview
VANCOUVER, BC, Oct. 7, 2025 /CNW/ - The following issues have been halted by CIRO:
Company: Affinor Growers Inc.
CSE Symbol: AFI
All Issues: Yes
Reason: Cease Trade Order
Halt Time (ET): 7:32 AM
CIRO can make a decision to impose a tempo...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Savara Inc. ("Savara" or "the Company") (NASDAQ: SVRA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulg...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SVRA
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Savara Inc. ("Savara " or "the Company") (NASDAQ: SVRA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exc...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US04280A1007
Arrowhead Pharmaceuticals Inc
ARWR
LISTED
NASDAQ
Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
News Preview
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-DIMER-PA, the company’s investigational RNA interference (RNAi) therapeutic being developed as a potential treatment for atherosclerotic cardiovascular disease (ASCVD) due to mixed hyper...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US74340E1038
Progyny Inc
PGNY
LISTED
NASDAQ
Progyny CEO Named World Economic Forum Champion for Women’s Health
News Preview
Progyny joins global leaders to accelerate advancement in research, innovation, and resilience in women’s health Progyny joins global leaders to accelerate advancement in research, innovation, and resilience in women’s health...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SMLR
News Preview
LOS ANGELES, Oct. 6, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Semler Scientific, Inc. ("Semler " or "the Company") (NASDAQ: SMLR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securi...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Altimmune, Inc. ("Altimmune" or "the Company") (NASDAQ: ALT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 p...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against LifeMD, Inc. ("LifeMD" or "the Company") (NASDAQ: LFMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promul...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against LifeMD, Inc. ("LifeMD " or "the Company") (NASDAQ: LFMD ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and E...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 pr...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US64049M2098
Neogenomics Inc
NEO
LISTED
NASDAQ
NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
News Preview
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its third quarter 2025 financial results prior to the open of the U.S. financial markets on Tuesday, October 28, 2025. Company management will host a webcast and conference call at 8:30 a.m. ET to...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs
News Preview
Highly scalable, cost-effective LongPlex™ kit delivers streamlined tagmentation and multiplexing for low-pass whole genome sequencing, plasmid resequencing, and microbial sequencing Highly scalable, cost-effective LongPlex™ kit delivers streamlined tagmentation and multiplexing for low-pass whole genome sequencing, plasmid resequencing, and microbi...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US8106481059
scPharmaceuticals, Inc.
SCPH
LISTED
NASDAQ
MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care
News Preview
DANBURY, Conn. and BURLINGTON, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc....
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US0070021086
Adicet Bio Inc
ACET
LISTED
NASDAQ
Adicet Bio, Inc. Announces $80 Million Registered Direct Offering
News Preview
Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the pricing of an underwritten registered direct offering of 70,001,000 shares of its common stock and, in lieu of common stock to certain investor...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US45168D1046
IDEXX Laboratories, Inc.
IDXX
LISTED
NASDAQ
IDEXX Laboratories Elects Karen Peacock to Board of Directors
News Preview
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Karen Peacock to the Company's Board of Directors, effective October 6, 2025.
"We are extremely pleased to welcome Karen to the IDEXX Board of Directors," said Lawrence D. Kingsley, the Company's Independent Non-Executive Board...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US29251M1062
Enanta Pharmaceuticals Inc
ENTA
LISTED
NASDAQ
Enanta Pharmaceuticals to Present Data for Zelicapavir and EDP-323, Two Candidates in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025
News Preview
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immunological diseases, today announced that data for zelicapavir, its oral, once-daily, N-protein inhibitor, and EDP-323, it’s oral, once-daily L-protein inhibitor, both in development for t...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis showcases transformational medicines and industry-leading pipeline at Innovation Day
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today is hosting its 2025 Innovation Day in New York City. Ionis leaders will highlight the company’s recent and near-term independent launches, growing pipeline of wholly owned medicines, innovative technology and clear path to sustained positive cash flow. Additionally, a leading physician will discuss...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the upcoming presentation of early clinical data on the treatment of atrial fibrillation (AF) using the nPulse™ Cardiac Surgical System at the 39th Euro...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US56400P2011
MannKind Corporation
MNKD
LISTED
NASDAQ
MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care
News Preview
MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US74276R1023
Privia Health Group Inc
PRVA
LISTED
NASDAQ
Privia Health to Report Third Quarter 2025 Results on Thursday, November 6
News Preview
Privia Health to Report Third Quarter 2025 Results on Thursday, November 6...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US6700021040
Novavax Inc
NVAX
LISTED
NASDAQ
Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment
News Preview
GAITHERSBURG, Md., Oct. 7, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the marketing authorization for its COVID-19 vaccine, Nuvaxovid® to Sanofi, in the European Union (EU) enabling Sanofi to take full responsibility for commercial and regulatory activities in the EU. The tran...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US30063P1057
Exact Sciences Corp
EXAS
LISTED
NASDAQ
New Study in Journal of the National Cancer Institute Finds Cologuard Plus™ Provides the Most Life-Years Gained with the Fewest Colonoscopies
News Preview
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests today announced the publication of “Comparing Benefit-to-Burden Ratios of Endorsed and Emerging Colorectal Cancer Screening Strategies” in the Journal of the National Cancer Institute.1 The modeling study found that Cologuard Plus™, a triennial next-ge...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US0070021086
Adicet Bio Inc
ACET
LISTED
NASDAQ
Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
News Preview
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced initial safety and efficacy data from the first seven patients dosed with ADI-001 in the ongoing Phase 1 study evaluating ADI-001 as a potential treatment for...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Completes Acquisition of Verona Pharma
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”) acquisition. Verona Pharma is now a wholly-owned subsidiary of Merck and the American Depositary Shares (ADS) of Verona Pharma will no longer be listed or traded on the Nasdaq Global Mark...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis
News Preview
Approximately 80% of Omvoh-treated patients in the LUCENT-3 study who achieved clinical remission at one year maintained long-term, corticosteroid-free clinical and endoscopic remission
At four years, nearly all patients who achieved clinical remission at one y...
Themefolio
Profiler
Peergroup
© Newsfile
07.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Signs Real Estate for Corporate Combo Store of iQ Food Co. and Heal Wellness in Toronto, Ontario
News Preview
Toronto, Ontario--(Newsfile Corp. - October 7, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada is pleased to announce the securing of a new prime real estate location in Toronto, which will be home to our second combination pairing...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
News Preview
$25.2 million in first closing, $1.2 million in second closing and $2.8 million in third and final closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment options $25.2 million in first closing, $1.2 million in second closing and $2.8 million in t...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US09077A1060
Biomea Fusion Inc
BMEA
LISTED
NASDAQ
Biomea Fusion Announces Pricing of Public Offering of Securities
News Preview
SAN CARLOS, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced the pricing of its previously announced underwritten public offering consisting of (i) 11,195,121 shares of its common stock and accompanying warrants to purchase an aggregate of 11,19...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US63909J1088
Nautilus Biotechnology Inc
NAUT
LISTED
NASDAQ
Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025
News Preview
SEATTLE, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the third quarter 2025 before market open on Tuesday, October 28, 2025....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
